Riskpilot← Back to searchSign inGet full accessDiaskop AB
ABDissolvedOrg 5590797956Medical specialists activities · NACE 8622Est. 20160 employees
Revenue 2023
SEK 136K
+5% vs 2022
EBITDA margin
98.5%
+16% vs 2022
Equity ratio
55.3%
Financial strength
Net profit 2023
SEK 107K
+53% vs 2022
| Revenue | SEK 136K | +5% |
| EBITDA | SEK 134K | +16% |
| Net profit | SEK 107K | +53% |
| Total assets | SEK 284K | -17% |
| Equity | SEK 157K | +31% |
| Employees | 0 | — |
Legal name
Diaskop AB
Org number
5590797956
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 oktober 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk diagnostik samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 229 | 129 | 136 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | — | 226 | 116 | 134 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −1 | 0 | 226 | 116 | 134 |
| Net financials | — | — | — | — | — |
| Profit before tax | −1 | 0 | 226 | 88 | 135 |
| Tax | −0 | −0 | −48 | −18 | −28 |
| Net profit | −1 | 0 | 178 | 70 | 107 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 40 | 40 | 266 | 344 | 284 |
| Equity | 40 | 40 | 218 | 120 | 157 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 48 | 196 | 100 |
| Total debt | — | — | 48 | 196 | 100 |
EBITDA margin
98.5%
This company
15.8%
Market median
+523% vs market
20192023
Equity ratio
55.3%
This company
38.2%
Market median
+45% vs market
20192023
Return on equity
68.2%
This company
18.4%
Market median
+271% vs market
20192023
Net profit margin
78.7%
This company
8.1%
Market median
+872% vs market
20192023
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20192023
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Diaskop AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Johan Torsson Lindgren | Chief Executive Officer | 0 companies |
| Alf Johan Wallander | Deputy Board Member | 0 companies |